Does Rallies show Form 4 insider transactions for ANGO?

Yes. Rallies tracks ANGO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ANGO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ANGO. It does not provide personalized investment advice.

ANGO (AngioDynamics, Inc.) Stock Analysis - Insider Trades

AngioDynamics, Inc. (ANGO) is a publicly traded Healthcare sector company. As of May 21, 2026, ANGO trades at $11.81 with a market cap of $457.40M and a P/E ratio of -15.46. ANGO moved +3.15% today. Year to date, ANGO is -10.73%; over the trailing twelve months it is +24.19%. Its 52-week range spans $5.83 to $13.99. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces ANGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ANGO stock inside the company?

Recent ANGO insider activity includes Weiss Lawrence T bought 10.00K, Trowbridge Stephen A bought 890, Clemmer James C bought 10.00K, Nighan Warren JR sold 4.06K, and Nighan Warren JR bought 100. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ANGO Key Metrics

Key financial metrics for ANGO
Metric	Value
Price	$11.81
Market Cap	$457.40M
P/E Ratio	-15.46
EPS	$-0.76
Dividend Yield	0.00%
52-Week High	$13.99
52-Week Low	$5.83
Volume	0
Avg Volume	0
Revenue (TTM)	$313.73M
Net Income	$-31.39M
Gross Margin	54.30%

Recent ANGO Insider Trades

Weiss Lawrence T bought 10.00K (~$118.10K) on Oct 21, 2025.
Trowbridge Stephen A bought 890 (~$9.93K) on Oct 13, 2025.
Clemmer James C bought 10.00K (~$111.50K) on Oct 9, 2025.
Nighan Warren JR sold 4.06K (~$49.98K) on Jan 16, 2025.
Nighan Warren JR bought 100 (~$608) on Oct 10, 2024.

Latest ANGO News

AngioDynamics Down 5.8% with RSI at 9.16 as EPS Estimates Rise 24.1% — Apr 11, 2026
AngioDynamics Raises Sales Guidance Again, EPS Loss Range $0.30 to $0.23 — Apr 2, 2026
AngioDynamics Q3 Revenue Rises 8.9% to $78.4M, EPS Misses Estimates — Apr 2, 2026
Veeva Systems Q4 EPS Rises 18.4% to $2.06; Revenues Hit $836M — Mar 5, 2026
AngioDynamics Expands NanoKnife EU Indications and Schedules Leerink Presentation — Feb 23, 2026

ANGO Analyst Consensus

3 analysts cover ANGO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.

Common questions about ANGO

Who is trading ANGO stock inside the company?: Recent ANGO insider activity includes Weiss Lawrence T bought 10.00K, Trowbridge Stephen A bought 890, Clemmer James C bought 10.00K, Nighan Warren JR sold 4.06K, and Nighan Warren JR bought 100. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ANGO?: Yes. Rallies tracks ANGO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ANGO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ANGO. It does not provide personalized investment advice.